International Neuroblastma Risk Groups Stages

Understanding the risk for relapse is important because there

are large differences between the treatments for low-risk,
intermediate-risk and high-risk disease. In general, high-risk
neuroblastomas are more likely to come back and therefore
require stronger treatment than low- or intermediate-risk
disease. Stronger treatment selected for high-risk disease has
been shown to benefit patients; however, it also has more side
effects. Therefore, risk assessment is an essential step in
determining appropriate treatment.
International teams of neuroblastoma specialists have
developed current treatment plans over several decades to
carefully balance the benefits and risks of treatment and the
chance that treatment will not be successful. Once your doctor
has completed all the necessary tests and has assigned a risk
category for your child, focus your attention on that particular
risk groups treatment section.